A multi-pathway perspective on protein aggregation: Implications for control of the rate and extent of amyloid formation

FEBS Letters

Volumn 589, Issue 6, 2015, Pages 672-679

  Hall, Damien ^a,b   Kardos, József ^c   Edskes, Herman ^d   Carver, John A ^a   Goto, Yuji ^b  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b OSAKA UNIVERSITY   (Japan)

^c EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Amorphous aggregation; Amyloid; Anti amyloid ligand screen; Competition; Kinetic model; Regulation

Indexed keywords

ACYLPHOSPHATASE; AMYLOID; EPIGALLOCATECHIN GALLATE; MONOMER; POLYMER; THIOFLAVINE; AMYLOID PRECURSOR PROTEIN;

AMYLOIDOSIS; ARTICLE; BINDING AFFINITY; DIFFUSION; DISSOCIATION CONSTANT; DRUG MECHANISM; FIBER; GEOMETRY; MATHEMATICAL MODEL; MICELLE; MOLECULAR SIZE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; AMYLOID PLAQUE; BIOLOGICAL MODEL; COMPUTER SIMULATION; HUMAN; KINETICS; METABOLISM; PROTEINOSIS;

AMYLOID BETA-PROTEIN PRECURSOR; AMYLOIDOSIS; COMPUTER SIMULATION; HUMANS; KINETICS; MODELS, BIOLOGICAL; PLAQUE, AMYLOID; PROTEIN AGGREGATION, PATHOLOGICAL;

EID: 84923602110     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2015.01.032     Document Type: Article

References (61)

1. G. Merlini, D.C. Seldin, and M.A. Gertz Amyloidosis: pathogenesis and new therapeutic options J. Clin. Oncol. 29 2011 1924 1933
2. J.D. Sipe, M.D. Benson, J.N. Buxbaum, S.I. Ikeda, G. Merlini, M.J. Saraiva, and P. Westermark Amyloid fibril protein nomenclature: 2012 recommendations from the Nomenclature Committee of the International Society of Amyloidosis Amyloid 19 2012 167 170
3. D. Hall, and H. Edskes Computational modeling of the relationship between amyloid and disease Biophys. Rev. 4 2012 205 222
4. H. Naiki, K. Higuchi, K. Nakakuki, and T. Takeda Kinetic analysis of amyloid fibril polymerization in vitro Lab. Invest. 65 1991 104 110
5. J.T. Jarrett, and P.T. Lansbury Jr Seeding "one- dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73 1993 1055 1058
6. A. Lomakin, D.S. Chung, G.B. Benedek, D.A. Kirschner, and D.B. Teplow On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants Proc. Natl. Acad. Sci. U.S.A. 93 1996 1125 1129
7. F. Oosawa, and S. Asakura Thermodynamics of the Polymerization of Protein 1975 Academic London
8. D. Hall, and A.P. Minton Effects of inert volume-excluding macromolecules on protein fiber formation. II. Kinetic models for nucleated fiber growth Biophys. Chem. 107 2004 299 316
9. K.J. Binger, C.L. Pham, L.M. Wilson, M.F. Bailey, L.J. Lawrence, P. Schuck, and G.J. Howlett Apolipoprotein C-II amyloid fibrils assemble via a reversible pathway that includes fibril breaking and rejoining J. Mol. Biol. 376 2008 1116 1129
10. P. Ghosh, A. Kumar, B. Datta, and V. Rangachari Dynamics of protofibril elongation and association involved in Ap42 peptide aggregation in Alzheimer's disease BMC Bioinform. 11 2010 S24
11. J.E. Gillam, and C.E. MacPhee Modelling amyloid fibril formation kinetics: mechanisms of nucleation and growth J. Phys. Condens. Matter 25 2013 373101
12. J. Qian, Y. Lu, A. Chia, M. Zhang, P.A. Rupar, N. Gunari, and M.A. Winnik Self-seeding in one dimension: a route to uniform fiber-like nanostructures from block copolymers with a crystallizable core-forming block ACS Nano 7 3754 2013 3766
13. Fändrich, M., Wulff, M., Pedersen, J. S., and Otzen, D. (2013). Fibrillar Polymorphism, in: D. Otzen (Ed.), Amyloid Fibrils and Prefibrillar Aggregates: Molecular and Biological Properties, Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany, pp. 321-343.
14. T. Ikenoue, Y.H. Lee, J. Kardos, H. Yagi, T. Ikegami, H. Naiki, and Y. Goto Heat of supersaturation-limited amyloid burst directly monitored by isothermal titration calorimetry Proc. Natl. Acad. Sci. U.S.A. 111 2014 6654 6659
15. A.M. Streets, Y. Sourigues, R.R. Kopito, R. Melki, and S.R. Quake Simultaneous measurement of amyloid fibril formation by dynamic light scattering and fluorescence reveals complex aggregation kinetics PLoS One 8 2013 e54541
16. P.B. Stathopulos, G.A. Scholz, Y.M. Hwang, J.A. Rumfeldt, J.R. Lepock, and E.M. Meiering Sonication of proteins causes formation of aggregates that resemble amyloid Protein Sci. 13 3017 2004 3027
17. Z. Qin, D. Hu, M. Zhu, and A.L. Fink Structural characterization of the partially folded intermediates of an immunoglobulin light chain leading to amyloid fibrillation and amorphous aggregation Biochemistry 46 2007 3521 3531
18. S.J. Wood, B. Maleeff, T. Hart, and R. Wetzel Physical, morphological and functional differences between pH 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide A β J. Mol. Biol. 256 1996 870 877
19. N.G. Bednarska, J. Schymkowitz, F. Rousseau, and J. Van Eldere Protein aggregation in bacteria: the thin boundary between functionality and toxicity Microbiology 159 2013 1795 1806
20. J.L. Jimenez, G. Tennent, M. Pepys, and H.R. Saibil Structural diversity of ex vivo amyloid fibrils studied by cryo-electron microscopy J. Mol. Biol. 311 2001 241 247
21. D. Hall, and H. Edskes Silent prions lying in wait: a two-hit model of prion/amyloid formation and infection J. Mol. Biol. 336 2004 775 786
22. D. Hall, and A.P. Minton Effects of inert volume-excluding macromolecules on protein fiber formation. I. Equilibrium models Biophys. Chem. 98 2002 93 104
23. D. Hall, and H. Edskes A model of amyloid's role in disease based on fibril fracture Biophys. Chem. 145 2009 17 28
24. D. Hall, N. Hirota, and C.M. Dobson A toy model for predicting the rate of amyloid formation from unfolded protein J. Mol. Biol. 351 2005 195 205
25. D. Hall, and N. Hirota Multi-scale modelling of amyloid formation from unfolded proteins using a set of theory derived rate constants Biophys. Chem. 140 2009 122 128
26. M. Elimelech, J. Gregory, J. Jia, and R. Williams Particle Deposition and Aggregation 1995 Butterworth and Heinemann (Chapter 6, pp. 157-204)
27. J.E. Straub, and D. Thirumalai Toward a molecular theory of early and late events in monomer to amyloid fibril formation Annu. Rev. Phys. Chem. 62 2011 437 463
28. T.P. Knowles, M. Vendruscolo, and C.M. Dobson The amyloid state and its association with protein misfolding diseases Nat. Rev. Mol. Cell Biol. 15 2014 384 396
29. Levine III, H. (1999) Quantification of β-sheet amyloid fibril structures with Thioflavin T, in: Wetzel, R. (Ed.), Methods in Enzymology: Amyloids, Prions and Other Protein Aggregates', vol. 309, pp. 274-284 (Chapter 18).
30. K.J. Binger, H. Ecroyd, S. Yang, J.A. Carver, G.J. Howlett, and M.D. Griffin Avoiding the oligomeric state: αB-crystallin inhibits fragmentation and induces dissociation of apolipoprotein C-II amyloid fibrils FASEB J. 27 2013 1214 1222
31. Wanker, E.E., Scherzinger, E., Heiser, V., Sittler, A., Eickhof, H., Hans Lehrach, (1999) Membrane filter assay for detection of amyloid like polyglutamine containing protein aggregates, in: R. Wetzel (Ed.), Methods in Enzymology: Amyloids, Prions and Other Protein Aggregates', vol. 309, pp. 375-385 (Chapter 24).
32. Naiki, H., Gejyo, F. (1999) Kinetic analysis of amyloid fibril formation, in: R. Wetzel (Ed.), Methods in Enzymology: Amyloids, Prions and Other Protein Aggregates, vol. 309, pp. 305-317 (Chapter 20).
33. Klunk, W.E., Jacob, R.F., Preston-Mason, R. (1999) Quantifying amyloid by Congo Red spectral assay, in: R. Wetzel (Ed.), Methods in Enzymology: Amyloids, Prions and Other Protein Aggregates', vol. 309, pp. 285-304 (Chapter 19).
34. Lomakin, A.L., Benedek, G., Teplow, D.B. (1999) Monitoring protein assembly using quasielastic light scattering spectroscopy, in: R. Wetzel (Ed.), Methods in Enzymology: Amyloids, Prions and Other Protein Aggregates, vol. 309, pp. 429-459 (Chapter 27).
35. E. Sahin, and C.J. Roberts Size-exclusion chromatography with multi-angle light scattering for elucidating protein aggregation mechanisms Therapeutic Proteins 2012 Humana Press 403 423
36. Levine III, H., Scholten, J.D. (1999) Screening for pharmacologic inhibitors of amyloid fibril formation, in: R. Wetzel (Ed.), Methods in Enzymology: Amyloids, Prions and Other Protein Aggregates, vol. 309, pp. 467-475 (Chapter 29).
37. E. Karran, M. Mercken, and B. De Strooper The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics Nat. Rev. Drug Discov. 10 2011 698 712
38. T. Härd, and C. Lendel Inhibition of amyloid formation J. Mol. Biol. 421 2012 441 465
39. G. Grelle, A. Otto, M. Lorenz, R.F. Frank, E.E. Wanker, and J. Bieschke Black tea theaflavins inhibit formation of toxic amyloid-β and α-synuclein fibrils Biochemistry 50 2011 10624 10636
40. M. Caruana, T. Högen, J. Levin, A. Hillmer, A. Giese, and N. Vassallo Inhibition and disaggregation of α-synuclein oligomers by natural polyphenolic compounds FEBS Lett. 585 2011 1113 1120
41. S. Di Giovanni, S. Eleuteri, K.E. Paleologou, G. Yin, M. Zweckstetter, P.A. Carrupt, and H.A. Lashuel Entacapone and tolcapone, two catechol O-methyltransferase inhibitors, block fibril formation of α-synuclein and β-amyloid and protect against amyloid-induced toxicity J. Biol. Chem. 285 2010 14941 14954
42. N. Pandey, J. Strider, W.C. Nolan, S.X. Yan, and J.E. Galvin Curcumin inhibits aggregation of α-synuclein Acta Neuropathol. 115 2008 479 489
43. M.A. Findeis Approaches to discovery and characterization of inhibitors of amyloid β-peptide polymerization Biochim. Biophys. Acta - Mol. Basis Dis. 1502 2000 76 84
44. S.M. Johnson, S. Connelly, C. Fearns, E.T. Powers, and J.W. Kelly The transthyretin amyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug J. Mol. Biol. 421 2012 185 203
45. F. Meng, A. Abedini, A. Plesner, C.B. Verchere, and D.P. Raleigh The flavanol (-)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against IAPP-induced toxicity Biochemistry 49 2010 8127 8133
46. S.A. Hudson, H. Ecroyd, F.C. Dehle, I.F. Musgrave, and J.A. Carver (-)-Epigallocatechin-3-gallate (EGCG) maintains kappa-casein in its pre-fibrillar state without redirecting its aggregation pathway J. Mol. Biol. 392 2009 689 700
47. J. Bieschke, J. Russ, R.P. Friedrich, D.E. Ehrnhoefer, H. Wobst, K. Neugebauer, and E.E. Wanker EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity Proc. Natl. Acad. Sci. 107 2010 7710 7715
48. F. Chiti, M. Stefani, N. Taddei, G. Ramponi, and C.M. Dobson Rationalization of the effects of mutations on peptide and protein aggregation rates Nature 424 2003 805 808
49. Chiti, F. (2006) Relative importance of hydrophobicity, net charge, and secondary structure propensities in protein aggregation, in: Protein Misfolding, Aggregation, and Conformational Diseases, Springer, US, pp. 43-59.
50. K.F. DuBay, A.P. Pawar, F. Chiti, J. Zurdo, C.M. Dobson, and M. Vendruscolo Prediction of the absolute aggregation rates of amyloidogenic polypeptide chains J. Mol. Biol. 341 2004 1317 1326
51. F. Chiti, P. Webster, N. Taddei, A. Clark, M. Stefani, G. Ramponi, and C.M. Dobson Designing conditions for in vitro formation of amyloid protofilaments and fibrils Proc. Natl. Acad. Sci. 96 1999 3590 3594
52. D.L. Craft, L.M. Wein, and D.J. Selkoe A mathematical model of the impact of novel treatments on the Ap burden in the Alzheimer's brain, CSF and plasma Bull. Math. Biol. 64 2002 1011 1031
53. M.K. Simmons, R. Manjeshwar, E.D. Agdeppa, R.M. Mattheyses, T.R. Kiehl, and M.C. Montalto A computational positron emission tomography simulation model for imaging β-amyloid in mice Mol. Imaging Biol. 7 2005 69 77
54. J.D. Gillmore, P.N. Hawkins, and M.B. Pepys Amyloidosis: a review of recent diagnostic and therapeutic developments Br. J. Haematol. 99 1997 245 256
55. F.B. Kenrick, K.L. Wismer, and K.S. Wyatt Supersaturation of gases in liquids J. Phys. Chem. 28 1924 1308 1315
56. G. Liger-Belair, M. Vignes-Adler, C. Voisin, B. Robillard, and P. Jeandet Kinetics of gas discharging in a glass of champagne: the role of nucleation sites Langmuir 18 2002 1294 1301
57. J.D. Harper, and P.T. Lansbury Jr. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins Annu. Rev. Biochem. 66 1997 385 407
58. Y. Yoshimura, Y. Lin, H. Yagi, Y.H. Lee, H. Kitayama, K. Sakurai, M. So, H. Ogi, H. Naiki, and Y. Goto Distinguishing crystal-like amyloid fibrils and glass-like amorphous aggregates from their kinetics of formation Proc. Natl. Acad. Sci. 109 2012 14446 14451
59. G.G. Hammes, and P.R. Schimmel Rapid reactions and transient states P.D. Boyer, The Enzymes vol. 2 1970 Academic Press New York 67 68
60. C.R. Cantor, and P.R. Schimmel Kinetics of ligand interactions Biophysical Chemistry 1980 W.H. Freeman and Company 920 921 (Chapter 16)
61. S.D. Stranks, H. Ecroyd, S. Van Sluyter, E.J. Waters, J.A. Carver, and L. von Smekal Model for amorphous aggregation processes Phys. Rev. E 80 2009 051907